血脂异常与结直肠锯齿状病变、结直肠癌相关性研究进展

doi:10.12114/j.issn.1007-9572.2023.0244

摘要/Abstract

摘要： 血脂水平异常可能与结直肠肿瘤的发生、发展有关。目前，众多研究证实血脂异常增加了患结直肠腺瘤的风险，然而血脂异常与结直肠锯齿状病变、结直肠癌的关联仍存在争议，并且国内相关综述较少。本文全面探讨了血脂异常与结直肠锯齿状病变、结直肠癌相关性，分析了可能造成争议的原因，指出后续的研究方向，并讨论了血脂异常在结直肠肿瘤发生、发展中发挥的作用，提示血脂异常与结直肠锯齿状病变、结直肠癌有关。血脂异常可能是通过胰岛素抵抗、炎性因子、氧化应激、高脂饮食、免疫抑制等多种机制相互作用参与了结直肠肿瘤的发生、发展。结直肠癌发病率逐年上升，而其具有较缓慢的自然病程和较明确的癌前病变，因此明确血脂指标与结直肠肿瘤的相关性，便于早期预防和有针对性的筛查，为未来制订有针对性的预防结直肠癌策略提供参考。

关键词: 高脂血症, 血脂异常, 结直肠肿瘤, 结直肠锯齿状病变, 结直肠癌, 综述

Abstract:

Dyslipidemia may be related to the occurrence and development of colorectal tumors. Numerous studies have confirmed that dyslipidemia increases the risk of colorectal adenomas at present; however, the association of dyslipidemia with colorectal serrated lesions and colorectal cancer is still controversial, and there are few relevant reviews in China. This article comprehensively explores the correlation of dyslipidemia with colorectal serrated lesions and colorectal cancer, analyzes the possible causes of controversy, identifies the directions of subsequent researches, and discusses the role of dyslipidemia in the occurrence and progression of colorectal tumors. This article indicates that dyslipidemia is associated with colorectal serrated lesions and colorectal cancer. Dyslipidemia may be involved in the development of colorectal tumors through the interaction of multiple mechanisms such as insulin resistance, inflammatory factors, oxidative stress, high-fat diet and immunosuppression. The incidence of colorectal cancer is increasing yearly with a relatively slower natural course and more definite precancerous lesions. Therefore, the clarification of correlation between lipid indexes and colorectal tumors can facilitate early prevention and targeted screening of colorectal tumors and provide a reference for formulating targeted prevention strategies for colorectal cancer.

Key words: Hyperlipidemias, Dyslipidemias, Colorectal neoplasms, Colorectal serrated lesions, Colorectal cancer, Review

冉东升,逯艳艳,辛春玲,等. 血脂异常与结直肠锯齿状病变、结直肠癌相关性研究进展[J]. 中国全科医学, 2024, 27(12): 1424-1430. DOI: 10.12114/j.issn.1007-9572.2023.0244.
RAN Dongsheng,LU Yanyan,XIN Chunling, et al. Research Progress on the Correlation of Dyslipidemia with Colorectal Serrated Lesions and Colorectal Cancer[J]. Chinese General Practice, 2024, 27(12): 1424-1430. DOI: 10.12114/j.issn.1007-9572.2023.0244.

参考文献 62

[1]	SUNG H, FERLAY J, SIEGEL R L，et al. Global cancer statistics 2020：GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin，2021,71(3):209-249. DOI：10.3322/caac.21660.
[2]	ZHANG L, CAO F, ZHANG G Y，et al. Trends in and predictions of colorectal cancer incidence and mortality in China from 1990 to 2025[J]. Front Oncol，2019,9:98. DOI：10.3389/fonc.2019.00098.
[3]	XIA C F, DONG X S, LI H，et al. Cancer statistics in China and United States，2022：profiles，trends，and determinants[J]. Chin Med J （Engl），2022,135(5):584-590. DOI：10.1097/CM9.0000000000002108.
[4]	MONACHESE M, MANKANEY G, EL-KHIDER F，et al. Association between baseline hyperplastic polyps and metachronous serrated lesions[J]. Gastrointest Endosc，2021,93(6):1401-1407.e1. DOI：10.1016/j.gie.2020.11.028.
[5]	SANO W, HIRATA D, TERAMOTO A，et al. Serrated polyps of the colon and rectum：remove or not?[J]. World J Gastroenterol，2020,26(19):2276-2285. DOI：10.3748/wjg.v26.i19.2276.
[6]	CROCKETT S D, NAGTEGAAL I D. Terminology，molecular features，epidemiology，and management of serrated colorectal neoplasia[J]. Gastroenterology，2019,157(4):949-966.e4. DOI：10.1053/j.gastro.2019.06.041.
[7]	SONG N, LIU F, HAN M，et al. Prevalence of overweight and obesity and associated risk factors among adult residents of northwest China：a cross-sectional study[J]. BMJ Open，2019,9(9):e028131. DOI：10.1136/bmjopen-2018-028131.
[8]	PASSARELLI M N, NEWCOMB P A. Blood lipid concentrations and colorectal adenomas：a systematic review and meta-analysis of colonoscopy studies in Asia，2000-2014[J]. Am J Epidemiol，2016,183(8):691-700. DOI：10.1093/aje/kwv294.
[9]	KIM J, LEE J Y, HWANG S W，et al. Risk factors of traditional serrated adenoma and clinicopathologic characteristics of synchronous conventional adenoma[J]. Gastrointest Endosc，2019,90(4):636-646.e9. DOI：10.1016/j.gie.2019.04.241.
[10]	MACARIE M, BATAGA S, MOCAN S，et al. Correlation of metabolic risk factors with sessile serrated lesions[J]. J Gastrointestin Liver Dis，2020,29(2):175-179. DOI：10.15403/jgld-507.
[11]	肖强，杨善峰，李祥. 结直肠腺瘤性息肉患者血脂水平的影响因素及相关性研究[J]. 安徽医学，2018,39(6):718-721. DOI：10.3969/j.issn.1000-0399.2018.06.024.
[12]	金辉，盛玲玲，杨再兴，等. 不同结直肠息肉类型患者血脂水平的临床分析[J]. 全科医学临床与教育，2021,19(3):221-223,235. DOI：10.13558/j.cnki.issn1672-3686.2021.003.008.
[13]	HANG D, HE X S, KVÆRNER A S，et al. Plasma biomarkers of insulin and the insulin-like growth factor axis，and risk of colorectal adenoma and serrated polyp[J]. JNCI Cancer Spectr，2019,3(3):pkz056. DOI：10.1093/jncics/pkz056.
[14]	DE PALMA F D E, D'ARGENIO V, POL J，et al. The molecular hallmarks of the serrated pathway in colorectal cancer[J]. Cancers（Basel），2019,11(7):1017. DOI：10.3390/cancers11071017.
[15]	TROVATO A, TURSHUDZHYAN A, TADROS M. Serrated lesions：a challenging enemy[J]. World J Gastroenterol，2021,27(34):5625-5629. DOI：10.3748/wjg.v27.i34.5625.
[16]	朱静兰. 619例患者的血脂与结直肠息肉发生发展的关系分析[D]. 衡阳：南华大学，2017.
[17]	FLISS-ISAKOV N, ZELBER-SAGI S, WEBB M，et al. Distinct metabolic profiles are associated with colorectal adenomas and serrated polyps[J]. Obesity （Silver Spring），2017,25(Suppl 2):S72-80. DOI：10.1002/oby.22001.
[18]	PYO J H, HA S Y, HONG S N，et al. Identification of risk factors for sessile and traditional serrated adenomas of the colon by using big data analysis[J]. J Gastroenterol Hepatol，2018,33(5):1039-1046. DOI：10.1111/jgh.14035.
[19]	TANG C T, LI J, YANG Z Z，et al. Different lipid metabolic profiles and their associated genes in sessile serrated adenoma or polyps compared to hyperplastic polyps[J]. Am J Cancer Res，2022,12(5):1982-1994.
[20]	XIE C X, WEN P W, SU J L，et al. Elevated serum triglyceride and low-density lipoprotein cholesterol promotes the formation of colorectal polyps[J]. BMC Gastroenterol，2019,19(1):195. DOI：10.1186/s12876-019-1115-9.
[21]	应斐，吕丽红，应丽丽，等. 结直肠息肉不同病理类型的危险因素分析[J]. 浙江医学，2019,41(6):579-582. DOI：10.12056/j.issn.1006-2785.2019.41.11.2017-1454.
[22]	潘程宇. 结直肠息肉与血脂水平的相关性研究[J]. 中国卫生标准管理，2019,10(23):16-18. DOI：10.3969/j.issn.1674-9316.2019.23.007.
[23]	武良琴，李小萍，何薇. 外周血血脂水平与结直肠息肉的相关性分析[J]. 医学综述，2021,27(14):2904-2908. DOI：10.3969/j.issn.1006-2084.2021.14.036.
[24]	WANG X R, ZOU Y B, ZHANG R X，et al. The relationship between serum lipid levels and colorectal serrated lesions：a systematic review and meta-analysis[J]. Front Physiol，2022,13:984586. DOI：10.3389/fphys.2022.984586.
[25]	CHUNG Y W, HAN D S, PARK Y K，et al. Association of obesity，serum glucose and lipids with the risk of advanced colorectal adenoma and cancer：a case-control study in Korea[J]. Dig Liver Dis，2006,38(9):668-672. DOI：10.1016/j.dld.2006.05.014.
[26]	董大庆，李炳庆，何培元. 血脂在结直肠癌中应用价值的研究[J]. 世界最新医学信息文摘，2019,19(6):199-201. DOI：10.3969/j.issn.1671-3141.2019.06.101.
[27]	何爽. 血脂指标及多项血清肿瘤标志物对结直肠癌的诊断价值[J]. 系统医学，2022,7(12):38-41. DOI：10.19368/j.cnki.2096-1782.2022.12.038.
[28]	TIAN Y, WANG K M, LI J，et al. The association between serum lipids and colorectal neoplasm：a systemic review and meta-analysis[J]. Public Health Nutr，2015,18(18):3355-3370. DOI：10.1017/S1368980015000646.
[29]	周璀，梁钰，侯利丹，等. 结直肠息肉与血脂异常关系的回顾性研究[J]. 国际消化病杂志，2020,40(5):314-318. DOI：10.3969/j.issn.1673-534X.2020.05.007.
[30]	YAO X, TIAN Z. Dyslipidemia and colorectal cancer risk：a meta-analysis of prospective studies[J]. Cancer Causes Control，2015,26(2):257-268. DOI：10.1007/s10552-014-0507-y.
[31]	YANG Z P, TANG H Z, LU S，et al. Relationship between serum lipid level and colorectal cancer：a systemic review and meta-analysis[J]. BMJ Open，2022,12(6):e052373. DOI：10.1136/bmjopen-2021-052373.
[32]	YUAN F C, WEN W Q, JIA G C，et al. Serum lipid profiles and cholesterol-lowering medication use in relation to subsequent risk of colorectal cancer in the UK biobank cohort[J]. Cancer Epidemiol Biomarkers Prev，2023,32(4):524-530. DOI：10.1158/1055-9965.EPI-22-1170.
[33]	FANG Z, HE M M, SONG M Y. Serum lipid profiles and risk of colorectal cancer：a prospective cohort study in the UK Biobank[J]. Br J Cancer，2021,124(3):663-670. DOI：10.1038/s41416-020-01143-6.
[34]	CHAPMAN T P, GOMES C F, LOUIS E，et al. De-escalation of immunomodulator and biological therapy in inflammatory bowel disease[J]. Lancet Gastroenterol Hepatol，2020,5(1):63-79. DOI：10.1016/S2468-1253(19)30186-4.
[35]	IBÁÑEZ-SANZ G, DÍEZ-VILLANUEVA A, RIERA-PONSATI M，et al. Mendelian randomization analysis rules out disylipidaemia as colorectal cancer cause[J]. Sci Rep，2019,9(1):13407. DOI：10.1038/s41598-019-49880-w.
[36]	毕崇尧，赫长胜，季志刚，等. 结直肠癌患者血浆胆固醇水平相关研究[J]. 结直肠肛门外科，2013,19(5):295-296. DOI：10.3969/j.issn.1009-6647.2006.01.008.
[37]	黄锐，刘超，张艳桥. 辛伐他汀用于结直肠癌治疗的系统综述[J]. 实用肿瘤学杂志，2021,35(4):365-369. DOI：10.11904/j.issn.1002-3070.2021.04.013.
[38]	郎吉萍，戴秋月，吕萍，等. 阿司匹林对结直肠癌化学预防作用的新进展[J]. 分子影像学杂志，2021,44(2):405-411. DOI：10.12122/j.issn.1674-4500.2021.02.38.
[39]	李玲，宋光耀. 健康体检者胰岛素抵抗与血脂异常的相关性及血脂最佳分界值的探讨[J]. 医学信息，2020,33(1):94-97. DOI：10.3969/j.issn.1006-1959.2020.01.028.
[40]	HENDERSON G C. Plasma free fatty acid concentration as a modifiable risk factor for metabolic disease[J]. Nutrients，2021,13(8):2590. DOI：10.3390/nu13082590.
[41]	LEROITH D, HOLLY J M P, FORBES B E. Insulin-like growth factors：ligands，binding proteins，and receptors[J]. Mol Metab，2021,52:101245. DOI：10.1016/j.molmet.2021.101245.
[42]	SHAO J Y, SHENG H M. Prostaglandin E2 induces the expression of IL-1α in colon cancer cells[J]. J Immunol，2007,178(7):4097-4103. DOI：10.4049/jimmunol.178.7.4097.
[43]	DE ARAÚJO W M, TANAKA M N, LIMA P H S，et al. TGF-β acts as a dual regulator of COX-2/PGE2 tumor promotion depending of its cross-interaction with H-Ras and Wnt/β-catenin pathways in colorectal cancer cells[J]. Cell Biol Int，2021,45(3):662-673. DOI：10.1002/cbin.11519.
[44]	HASHIMOTO T, OGAWA R, YOSHIDA H，et al. Acquisition of WNT pathway gene alterations coincides with the transition from precursor polyps to traditional serrated adenomas[J]. Am J Surg Pathol，2019,43(1):132-139. DOI：10.1097/PAS.0000000000001149.
[45]	周林香，沈磊. 结直肠无蒂锯齿状腺瘤的研究进展[J]. 中华消化内镜杂志，2021,38(12):1035-1040. DOI：10.3760/cma.j.cn321463-20200619-00349.
[46]	KASPRZAK A. Insulin-like growth factor 1 （IGF-1） signaling in glucose metabolism in colorectal cancer[J]. Int J Mol Sci，2021,22(12):6434. DOI：10.3390/ijms22126434.
[47]	KASPRZAK A. Autophagy and the insulin-like growth factor （IGF） system in colonic cells：implications for colorectal neoplasia[J]. Int J Mol Sci，2023,24(4):3665. DOI：10.3390/ijms24043665.
[48]	ROHR M W, NARASIMHULU C A, RUDESKI-ROHR T A，et al. Negative effects of a high-fat diet on intestinal permeability：a review[J]. Adv Nutr，2020,11(1):77-91. DOI：10.1093/advances/nmz061.
[49]	SHEN Y M, WANG C H, REN Y Z，et al. A comprehensive look at the role of hyperlipidemia in promoting colorectal cancer liver metastasis[J]. J Cancer，2018,9(16):2981-2986. DOI：10.7150/jca.25640.
[50]	LIU T, ZHANG Q S, SONG C H，et al. C-reactive protein trajectories and the risk of all cancer types：a prospective cohort study[J]. Int J Cancer，2022,151(2):297-307. DOI：10.1002/ijc.34012.
[51]	BOWIE R V, DONATELLO S, LYES C，et al. Lipid rafts are disrupted in mildly inflamed intestinal microenvironments without overt disruption of the epithelial barrier[J]. Am J Physiol Gastrointest Liver Physiol，2012,302(8):G781-793. DOI：10.1152/ajpgi.00002.2011.
[52]	ESTEVE E, RICART W, FERNÁNDEZ-REAL J M. Dyslipidemia and inflammation：an evolutionary conserved mechanism[J]. Clin Nutr，2005,24(1):16-31. DOI：10.1016/j.clnu.2004.08.004.
[53]	GONÇALVES A C. Oxidative stress and high-density lipoprotein cholesterol：cause or consequence?[J]. Revista Portuguesa De Cardiol，2022,41(10):841-842. DOI：10.1016/j.repc.2022.06.006.
[54]	MOHAMMAD S, THIEMERMANN C. Role of metabolic endotoxemia in systemic inflammation and potential interventions[J]. Front Immunol，2020,11:594150. DOI：10.3389/fimmu.2020.594150.
[55]	KING R J, SINGH P K, MEHLA K. The cholesterol pathway：impact on immunity and cancer[J]. Trends Immunol，2022,43(1):78-92. DOI：10.1016/j.it.2021.11.007.
[56]	BEYAZ S, MANA M D, ROPER J，et al. High-fat diet enhances stemness and tumorigenicity of intestinal progenitors[J]. Nature，2016,531(7592):53-58. DOI：10.1038/nature17173.
[57]	PENG X, HE Y E, HUANG J，et al. Metabolism of dendritic cells in tumor microenvironment：for immunotherapy[J]. Front Immunol，2021,12:613492. DOI：10.3389/fimmu.2021.613492.
[58]	WU H, HAN Y J, RODRIGUEZ SILLKE Y，et al. Lipid droplet-dependent fatty acid metabolism controls the immune suppressive phenotype of tumor-associated macrophages[J]. EMBO Mol Med，2019,11(11):e10698. DOI：10.15252/emmm.201910698.
[59]	LIU T C, KERN J T, JAIN U，et al. Western diet induces Paneth cell defects through microbiome alterations and farnesoid X receptor and type I interferon activation[J]. Cell Host Microbe，2021,29(6):988-1001.e6. DOI：10.1016/j.chom.2021.04.004.
[60]	TANG W S, ZHOU J Y, YANG W Q，et al. Aberrant cholesterol metabolic signaling impairs antitumor immunosurveillance through natural killer T cell dysfunction in obese liver[J]. Cell Mol Immunol，2022,19(7):834-847. DOI：10.1038/s41423-022-00872-3.
[61]	MA X Z, BI E G, LU Y，et al. Cholesterol induces CD₈⁺ T cell exhaustion in the tumor microenvironment[J]. Cell Metab，2019,30(1):143-156.e5. DOI：10.1016/j.cmet.2019.04.002.
[62]	KANG X, ZHANG R, KWONG T N，et al. Serrated neoplasia in the colorectum：gut microbiota and molecular pathways[J]. Gut Microbes，2021,13(1):1-12. DOI：10.1080/19490976.2020.1863135.